eMudhra IPO: The company intends to utilize the net proceeds from the fresh issue to pre-pay or repay in part or full, the existing loans availed by the company to an extent of Rs 35 crore. Rs 40.2 crore will be used for funding its working capital requirements.
Ethos IPO: The luxury watch retailer aims to raise garner Rs 472 crore through the fresh issue of shares aggregating to Rs 375 crore and an offer for sale of 1,108,037 worth Rs 97.29 crore
eMudhra IPO, at over 100x FY21 PE, is overpriced and ill-timed when the primary market is becoming unfriendly
Experts are of the opinion that higher valuations demanded by the company for the issue was among the main reasons for the lackluster response to the IPO.
The stock was already seeing muted volumes in the grey market after the IPO saw a dull response from retail and high net worth investors.
The company intends to garner about Rs 413 crore through fresh issue of equity shares upto Rs 161 crore and an offer for sale of of upto Rs 252 crore by the shareholders and promoters.
Choice Equity Broking has come out with its report on eMudhra. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 19, 2022.
The IPO, sized at Rs 413 crore, comprises fresh shares of Rs 161 crore and an offer for sale worth Rs 252 crore by shareholders and promoters.
Ethos IPO: After the issue, promoter holding will decline 19.36 percent to 61.65 percent
The company aims to mop up Rs 1,501 crore in total from a fresh issue of shares worth Rs 1,004 crore and an offer for sale of Rs 497.73 crore
Arihant Capital has come out with its report on eMudhra. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 19, 2022.
Earlier, the firm said its IPO will open on 24 May for subscription and close on 26 May. The basis of allotment expected on May 31, credit of shares expected on Jun 2 and the firm may be listed on exchanges on 3 June.
Hem Securities has come out with its report on Paradeep Phosphates. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 17, 2022.
Hem Securities has come out with its report on Ethos. The research firm has recommended to ''Subscribe'' the ipo in its research report as on May 17, 2022.
The IPO consists of a fresh issue of Rs 627 crore and an offer for sale of up to 2.82 million shares by its shareholders and promoters
Ethos IPO: The company plans to garner Rs 472 crore through fresh issue of equity shares aggregating to Rs 375 crore and Rs 97.29 crore through the sale of 1,108,037 shares by the shareholders and promoters
Around 50 percent of the net offer will be reserved for QIBs, 35 percent for retail investors, and the remaining 15 percent for non-institutional investors.
LIC share price is likely to drift lower to catch up with its fundamental value. How long does it take will depend upon whether free market operates or some institution(s) keep propping up the price
The brokerages are optimistic about the growth prospects of the company as the Indian watch market is sizeable and pegged at Rs 13,500 crore in FY 2020. It is expected to grow at a ~10.6 percent CAGR over FY20-25E to reach Rs 22,300 crores
Aramco, which recently became the world’s most valuable company, could sell a 30% stake in the division
Ethos intends to raise around Rs 472 crore through the public issue that comprises a fresh issue of equity shares and offer for sale by the promoters and shareholders.
At close, the stock settled at Rs 872.70 on the BSE, down 8.04% from issue price of Rs 949, while its mcap stood at Rs 5.52 trillion
The insurance behemoth will try to arrest its market share loss, ramp up its digital channels and make tactical tweaks on equity investments to please policyholders, Chairman MR Kumar says
The company aims to mop up Rs 1,501 crore by a combination of fresh issue of equity shares aggregating upto Rs 1,004 crore and an offer for sale (OFS) of 118,507,493 equity shares of Rs 10 each aggregating up to Rs 497.73 crore.
Choice Equity Broking has come out with its report on Ethos. The research firm has recommended to ''Avoid'' the ipo in its research report as on May 14, 2022.